These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 26590099)

  • 1. Qishenyiqi Dropping Pill attenuates myocardial fibrosis in rats by inhibiting RAAS-mediated arachidonic acid inflammation.
    Wang J; Lu L; Wang Y; Wu Y; Han J; Wang W; Li C; Tu P
    J Ethnopharmacol; 2015 Dec; 176():375-84. PubMed ID: 26590099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of DanQi Pill on PPARα, lipid disorders and arachidonic acid pathway in rat model of coronary heart disease.
    Chang H; Wang Q; Shi T; Huo K; Li C; Zhang Q; Wang G; Wang Y; Tang B; Wang W; Wang Y
    BMC Complement Altern Med; 2016 Mar; 16():103. PubMed ID: 27000070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Qishenyiqi protects ligation-induced left ventricular remodeling by attenuating inflammation and fibrosis via STAT3 and NF-κB signaling pathway.
    Li C; Wang Y; Qiu Q; Shi T; Wu Y; Han J; Chai X; Wang W
    PLoS One; 2014; 9(8):e104255. PubMed ID: 25122164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mechanisms of Fufang Danshen tablets on treating heart failure via regulating AT₁-mediated PLA2-COX2/5-LOX metabolic pathway].
    Zhang Y; Wang Y; Meng H; Lu WJ; Wang QX; Zhang Q; Li C; Tu PF
    Zhongguo Zhong Yao Za Zhi; 2018 Jun; 43(12):2593-2599. PubMed ID: 29950081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of QSYQ on anti-apoptosis mediated by different subtypes of cyclooxygenase in AMI induced heart failure rats.
    Wang J; Li C; Cao Y; Wang Q; Lu L; Chang H; Wu Y; Han J; Wang W; Tu P; Wang Y
    BMC Complement Altern Med; 2015 Oct; 15():352. PubMed ID: 26445960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Luhong formula inhibits myocardial fibrosis in a paracrine manner by activating the gp130/JAK2/STAT3 pathway in cardiomyocytes.
    Qu H; Wang Y; Wang Y; Yang T; Feng Z; Qu Y; Zhou H
    J Ethnopharmacol; 2017 Apr; 202():28-37. PubMed ID: 28115285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Qishen granule attenuates cardiac fibrosis by regulating TGF-β /Smad3 and GSK-3β pathway.
    Zeng Z; Wang Q; Yang X; Ren Y; Jiao S; Zhu Q; Guo D; Xia K; Wang Y; Li C; Wang W
    Phytomedicine; 2019 Sep; 62():152949. PubMed ID: 31102891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baoyuan decoction ameliorates apoptosis via AT1-CARP signaling pathway in H9C2 cells and heart failure post-acute myocardial infarction rats.
    Wang X; Meng H; Wang Q; Shao M; Lu W; Chen X; Jiang Y; Li C; Wang Y; Tu P
    J Ethnopharmacol; 2020 Apr; 252():112536. PubMed ID: 31931161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tanshinone II A attenuates inflammatory responses of rats with myocardial infarction by reducing MCP-1 expression.
    Ren ZH; Tong YH; Xu W; Ma J; Chen Y
    Phytomedicine; 2010 Mar; 17(3-4):212-8. PubMed ID: 19800776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artemisinin attenuates post-infarct myocardial remodeling by down-regulating the NF-κB pathway.
    Gu Y; Wang X; Wang X; Yuan M; Wu G; Hu J; Tang Y; Huang C
    Tohoku J Exp Med; 2012 Jul; 227(3):161-70. PubMed ID: 22729178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corydalis hendersonii Hemsl. protects against myocardial injury by attenuating inflammation and fibrosis via NF-κB and JAK2-STAT3 signaling pathways.
    Bai R; Yin X; Feng X; Cao Y; Wu Y; Zhu Z; Li C; Tu P; Chai X
    J Ethnopharmacol; 2017 Jul; 207():174-183. PubMed ID: 28629818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Qiliqiangxin Attenuates Cardiac Remodeling via Inhibition of TGF-β1/Smad3 and NF-κB Signaling Pathways in a Rat Model of Myocardial Infarction.
    Han A; Lu Y; Zheng Q; Zhang J; Zhao Y; Zhao M; Cui X
    Cell Physiol Biochem; 2018; 45(5):1797-1806. PubMed ID: 29510381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pirfenidone controls the feedback loop of the AT1R/p38 MAPK/renin-angiotensin system axis by regulating liver X receptor-α in myocardial infarction-induced cardiac fibrosis.
    Li C; Han R; Kang L; Wang J; Gao Y; Li Y; He J; Tian J
    Sci Rep; 2017 Jan; 7():40523. PubMed ID: 28091615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testosterone improves cardiac function and alters angiotensin II receptors in isoproterenol-induced heart failure.
    Kang NN; Fu L; Xu J; Han Y; Cao JX; Sun JF; Zheng M
    Arch Cardiovasc Dis; 2012 Feb; 105(2):68-76. PubMed ID: 22424324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of Chinese herbs and its effective components on coronary heart disease through PPARs-PGC1α pathway.
    Wang Q; Li C; Zhang Q; Wang Y; Shi T; Lu L; Zhang Y; Wang Y; Wang W
    BMC Complement Altern Med; 2016 Dec; 16(1):514. PubMed ID: 27955667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Qiliqiangxin improves cardiac function and attenuates cardiac remodeling in rats with experimental myocardial infarction.
    Wang J; Zhou J; Ding X; Zhu L; Jiang K; Fu M; Wang S; Hu K; Ge J
    Int J Clin Exp Pathol; 2015; 8(6):6596-606. PubMed ID: 26261541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. QiShenYiQi dripping pill alleviates myocardial ischemia-induced ferroptosis via improving mitochondrial dynamical homeostasis and biogenesis.
    Wu L; Fan Z; Gu L; Liu J; Cui Z; Yu B; Kou J; Li F
    J Ethnopharmacol; 2023 May; 308():116282. PubMed ID: 36806343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Angiotensin II type 1 receptor autoantibody induces myocardial fibrosis by activating cardiac fibroblasts].
    Hao WW; Zhang SL; Sun Y; Bai LN; Bian JW; Yu HC; Yin XC; Wang PL; Liu HR
    Sheng Li Xue Bao; 2018 Aug; 70(4):343-353. PubMed ID: 30112559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dragon's Blood exerts cardio-protection against myocardial injury through PI3K-AKT-mTOR signaling pathway in acute myocardial infarction mice model.
    Li C; Zhang Y; Wang Q; Meng H; Zhang Q; Wu Y; Xiao W; Wang Y; Tu P
    J Ethnopharmacol; 2018 Dec; 227():279-289. PubMed ID: 30195568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Spironolactone: renaissance of anti-aldosterone therapy in heart failure?].
    Brilla CG; Schencking M; Scheer C; Rupp H
    Praxis (Bern 1994); 1997 Apr; 86(14):566-74. PubMed ID: 9198851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.